Literature DB >> 22935517

Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.

Shuji Ogino1, Emily E King, Andrew H Beck, Mark E Sherman, Danny A Milner, Edward Giovannucci.   

Abstract

In recent decades, epidemiology, public health, and medical sciences have been increasingly compartmentalized into narrower disciplines. The authors recognize the value of integration of divergent scientific fields in order to create new methods, concepts, paradigms, and knowledge. Herein they describe the recent emergence of molecular pathological epidemiology (MPE), which represents an integration of population and molecular biologic science to gain insights into the etiologies, pathogenesis, evolution, and outcomes of complex multifactorial diseases. Most human diseases, including common cancers (such as breast, lung, prostate, and colorectal cancers, leukemia, and lymphoma) and other chronic diseases (such as diabetes mellitus, cardiovascular diseases, hypertension, autoimmune diseases, psychiatric diseases, and some infectious diseases), are caused by alterations in the genome, epigenome, transcriptome, proteome, metabolome, microbiome, and interactome of all of the above components. In this era of personalized medicine and personalized prevention, we need integrated science (such as MPE) which can decipher diseases at the molecular, genetic, cellular, and population levels simultaneously. The authors believe that convergence and integration of multiple disciplines should be commonplace in research and education. We need to be open-minded and flexible in designing integrated education curricula and training programs for future students, clinicians, practitioners, and investigators.

Entities:  

Mesh:

Year:  2012        PMID: 22935517      PMCID: PMC3571252          DOI: 10.1093/aje/kws226

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  86 in total

Review 1.  Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field.

Authors:  Shuji Ogino; Andrew T Chan; Charles S Fuchs; Edward Giovannucci
Journal:  Gut       Date:  2010-10-29       Impact factor: 23.059

2.  Identification of clinically useful cancer prognostic factors: what are we missing?

Authors:  Lisa M McShane; Douglas G Altman; Willi Sauerbrei
Journal:  J Natl Cancer Inst       Date:  2005-07-20       Impact factor: 13.506

3.  Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP.

Authors:  Lasse Sommer Kristensen; Helene Myrtue Nielsen; Henrik Hager; Lise Lotte Hansen
Journal:  Lung Cancer       Date:  2010-06-02       Impact factor: 5.705

4.  Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.

Authors:  Wade S Samowitz; Hans Albertsen; Carol Sweeney; Jennifer Herrick; Bette J Caan; Kristin E Anderson; Roger K Wolff; Martha L Slattery
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

5.  Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.

Authors:  Teppei Morikawa; Aya Kuchiba; Mai Yamauchi; Jeffrey A Meyerhardt; Kaori Shima; Katsuhiko Nosho; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

6.  Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.

Authors:  Stefan de Vogel; Kim A D Wouters; Ralph W H Gottschalk; Frederik J van Schooten; Anton F P M de Goeij; Adriaan P de Bruïne; Royle A Goldbohm; Piet A van den Brandt; Matty P Weijenberg; Manon van Engeland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

7.  The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer.

Authors:  Wade S Samowitz; Karen Curtin; Roger K Wolff; Hans Albertsen; Carol Sweeney; Bette J Caan; Cornelia M Ulrich; John D Potter; Martha L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2008-10       Impact factor: 5.006

8.  MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.

Authors:  Nicholas J Hawkins; James H-F Lee; Justin J-L Wong; Chau-To Kwok; Robyn L Ward; Megan P Hitchins
Journal:  Mod Pathol       Date:  2009-09-04       Impact factor: 7.842

9.  Detection of viral DNA sequences in sporadic colorectal cancers in relation to CpG island methylation and methylator phenotype.

Authors:  Pawel Karpinski; Aleksander Myszka; David Ramsey; Wojciech Kielan; Maria Malgorzata Sasiadek
Journal:  Tumour Biol       Date:  2011-04-06

Review 10.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

Authors:  Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  39 in total

1.  Buddy Study: Partners for better health in adolescents with type 2 diabetes.

Authors:  Allison C Sylvetsky; Radha Nandagopal; Tammy T Nguyen; Marisa R Abegg; Mahathi Nagarur; Paul Kaplowitz; Kristina I Rother
Journal:  World J Diabetes       Date:  2015-12-25

2.  Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle.

Authors:  Shuji Ogino; Edward Giovannucci
Journal:  Int J Epidemiol       Date:  2012-05-16       Impact factor: 7.196

Review 3.  Upper gastrointestinal bleeding risk scores: Who, when and why?

Authors:  Sara Monteiro; Tiago Cúrdia Gonçalves; Joana Magalhães; José Cotter
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

4.  Shuji Ogino: a critical mass of pathological epidemiologists is needed for transdisciplinary studies.

Authors:  Brad Li
Journal:  Transl Gastroenterol Hepatol       Date:  2018-12-04

Review 5.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

6.  "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.

Authors:  Tram Kim Lam; Margaret Spitz; Sheri D Schully; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-15       Impact factor: 4.254

Review 7.  Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.

Authors:  Paul Lochhead; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Kana Wu; Reiko Nishihara; Michael O'Brien; Shuji Ogino
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

Review 8.  How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.

Authors:  Shuji Ogino; Charles S Fuchs; Edward Giovannucci
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

9.  Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.

Authors:  Akiko Hanyuda; Sun A Kim; Alejandro Martinez-Fernandez; Zhi Rong Qian; Mai Yamauchi; Reiko Nishihara; Teppei Morikawa; Xiaoyun Liao; Kentaro Inamura; Kosuke Mima; Yin Cao; Xuehong Zhang; Kana Wu; Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Ramesh A Shivdasani; Shuji Ogino
Journal:  Ann Surg Oncol       Date:  2015-11-17       Impact factor: 5.344

10.  Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.

Authors:  Teppei Morikawa; Aya Kuchiba; Paul Lochhead; Reiko Nishihara; Mai Yamauchi; Yu Imamura; Xiaoyun Liao; Zhi Rong Qian; Kimmie Ng; Andrew T Chan; Jeffrey A Meyerhardt; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Res       Date:  2013-02-26       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.